Petrenko et al. [29] reported that CD146+ cells percentage was approximately in 30% of Wharton jelly MSCs (WJ-MSCs), but below 5% of BM-MSCs and AD-MSCs. This evidence concerns the gene MCAM and Alzheimer disease.